| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Center for Psychobiological and Psychosomatic Research, University of Trier (M.E., A.B.-K., D.H., S.K., N.R., C.K.), D-54286 Trier, Germany; Department of Medical Sciences, University of Edinburgh (B.W.), EH4 2XU Edinburgh, United Kingdom; and Department of Psychology, University of Düsseldorf (C.K.), D-40225 Düsseldorf, Germany
Address all correspondence and requests for reprints to: Prof. Dr. Clemens Kirschbaum, Department of Psychology, Heinrich Heine Universität Düsseldorf, Universitätsstrasse 1, D-40225 Düsseldorf, Germany. E-mail: ck{at}uni-duesseldorf.de
Contradicting data exist as to whether interindividual patterns in
glucocorticoid (GC) sensitivity vary between different target tissues
in humans. This study therefore measured GC sensitivity in 36 healthy
subjects in three target tissues: the immune system; the cardiovascular
system, and the hypothalamus-pituitary-adrenal axis. For this purpose,
dexamethasone inhibition of lipopolysaccharide-induced interleukin-6
and tumor necrosis factor-
production in peripheral leukocytes,
beclomethasone dipropionate-induced skin blanching, and suppression of
cortisol levels after low-dose (0.5 mg) dexamethasone suppression test
were determined in each subject.
The results showed the expected glucocorticoid-induced suppression of
interleukin-6 and tumor necrosis factor-
production (both
P < 0.001), dose-dependent skin blanching
(P < 0.001), and suppression of salivary cortisol
response to awakening (P < 0.001). However,
neither simple correlations nor cluster analysis revealed a significant
association among the three bioassays for GC sensitivity. In contrast
to the idea that interindividual variation in GC sensitivity is an
intrinsic trait affecting all tissues, these results suggest that this
variability is target tissue specific in healthy subjects.
This article has been cited by other articles:
![]() |
S. Kern and T. Ziemssen Review: Brain immune communication psychoneuroimmunology of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 6 - 21. [Abstract] [PDF] |
||||
![]() |
R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Miller, N. Rohleder, C. Stetler, and C. Kirschbaum Clinical Depression and Regulation of the Inflammatory Response During Acute Stress Psychosom Med, September 1, 2005; 67(5): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
P H Wirtz, R von Kanel, N Rohleder, and J E Fischer Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors Heart, August 1, 2004; 90(8): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wust, E. F. C. van Rossum, I. S. Federenko, J. W. Koper, R. Kumsta, and D. H. Hellhammer Common Polymorphisms in the Glucocorticoid Receptor Gene Are Associated with Adrenocortical Responses to Psychosocial Stress J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vermeer, B. I. Hendriks-Stegeman, B. van der Burg, S. C. van Buul-Offers, and M. Jansen Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 277 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gaab, D. Huster, R. Peisen, V. Engert, T. Schad, T. H. Schurmeyer, and U. Ehlert Low-Dose Dexamethasone Suppression Test in Chronic Fatigue Syndrome and Health Psychosom Med, March 1, 2002; 64(2): 311 - 318. [Abstract] [Full Text] |
||||
![]() |
L Patel, J K Wales, M S Kibirige, A A Massarano, J M Couriel, P E Clayton, and G. RUSSELL Symptomatic adrenal insufficiency during inhaled corticosteroid treatment Arch. Dis. Child., October 1, 2001; 85(4): 330 - 334. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |